Skip to main content
Clinical Trials/NL-OMON26162
NL-OMON26162
Not Yet Recruiting
N/A

A study on the pharmacokinetics of [18F]-fluordihydrotestosterone in patients with metastasized castrate resistant prostate cancer

VU university Medical Center0 sites10 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
VU university Medical Center
Enrollment
10
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
VU university Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients with mCRPC eligible for the GAP2\-FDHT study
  • \- Written informed consent

Exclusion Criteria

  • \- Claustrophobia
  • \- Multiple malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials